Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Scientific Reports
|
September 30, 2016
The Golgi associated ERI3 is a Flavivirus host factor
Alex Michael Ward, Meredith E K Calvert, Leah R Read, et al.
Elife
|
October 24, 2023
Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes
Xiang Wang, Vitaliy V Bondar, Oliver B Davis, et al.
Nature Communications
|
February 20, 2025
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution
Nathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Nature Communications
|
April 15, 2026
Author Correction: Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution
Nathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Science Translational Medicine
|
May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
The Journal of Experimental Medicine
|
February 28, 2022
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme
Annie Arguello, Cathal S Mahon, Meredith E K Calvert, et al.
Cell Reports
|
July 24, 2025
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules
Robert C Wells, Padma Akkapeddi, Darren Chan, et al.
Cell
|
November 12, 2024
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
Jing L Guo, Dylan Braun, Gabriel A Fitzgerald, et al.
Nature Communications
|
August 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial
Brittany N Flores, Seungyoon B Yu, Isaac V Cohen, et al.
Nature Communications
|
September 7, 2023
Author Correction: CD98hc is a target for brain delivery of biotherapeutics
Kylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Scientific Reports
|
September 30, 2016
The Golgi associated ERI3 is a Flavivirus host factor
Alex Michael Ward, Meredith E K Calvert, Leah R Read, et al.
Elife
|
October 24, 2023
Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes
Xiang Wang, Vitaliy V Bondar, Oliver B Davis, et al.
Nature Communications
|
February 20, 2025
Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution
Nathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Nature Communications
|
April 15, 2026
Author Correction: Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution
Nathalie Khoury, Michelle E Pizzo, Claire B Discenza, et al.
Science Translational Medicine
|
May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys
Mihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
The Journal of Experimental Medicine
|
February 28, 2022
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzyme
Annie Arguello, Cathal S Mahon, Meredith E K Calvert, et al.
Cell Reports
|
July 24, 2025
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large molecules
Robert C Wells, Padma Akkapeddi, Darren Chan, et al.
Cell
|
November 12, 2024
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes
Jing L Guo, Dylan Braun, Gabriel A Fitzgerald, et al.
Nature Communications
|
August 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial
Brittany N Flores, Seungyoon B Yu, Isaac V Cohen, et al.
Nature Communications
|
September 7, 2023
Author Correction: CD98hc is a target for brain delivery of biotherapeutics
Kylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Page
of 3